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ICU outcomeAbstract Introduction: Severe community acquired pneumonia (SCAP) occurs in approximately
18–36% of all CAP and the mortality rate could be as high as 67% in patients with SCAP. Several
studies have described a correlation between baseline lactate concentration and mortality of ICU
patients.
Aim of the work: To follow lactate clearance after admission for 24 h which could be an indicator
of outcome in severe community acquired pneumonia.
Patients and methods: Forty-six consecutively admitted adult patients were diagnosed as severe
community acquired pneumonia. Lactate was measured at the time of admission (H0), reassessment
of lactate level was done after 8 h and also another lactate measurement done after 24 h. In a trial to
follow the guideline for management and to optimize oxygen delivery (DO2) and reach a
ScvO2P 70%, ScvO2 was measured through a central venous blood sample done at the same time
with lactate. During the study resuscitation by inotropic medications and patient’s physiological
parameters were measured routinely. All data needed to calculate the Acute Physiology and
Chronic Health Evaluation (APACHE II) score were recorded.
Results: Most of patients in the current study were above the age of 60 years. Twenty-ﬁve
patients had lactate clearance of more than 40%, those patients were included in group 1, whereas
21 had lactate clearance of 40% or less and they were included in group II. There was no signiﬁcant
difference in the age and sex distribution between both groups. Out of 21 patients included in group
II, inotropic drugs were used in 8 patients (38%), whereas there was one patient only in group 1.
The rate of intubation in addition to the mean APACHE II score and ICU length of stay was sig-
niﬁcantly higher in group II compared to group I. Over the ﬁrst 24 h three readings for mixed
venous oxygen were recorded and included in the analysis. The reading of mixed venous oxygen
recorded after 24 h of ICU admission was signiﬁcantly high in group 1. All indices of blood lactate
1054 K.A.E. Mohamed, D.A.E. Ahmedclearance over the ﬁrst 24 h were higher in group 1 compared to group II, however it was only sig-
niﬁcantly high after 24 h (p-value 0.01).
Conclusion: Our study suggests that lactate clearance could be used as a useful biomarker which
is inexpensive and a reliable predictor of patient outcome in critically ill patients admitted to ICU
with severe community-acquired pneumonia.
ª 2014 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis. Open access under CC BY-NC-ND license.IntroductionPatients admitted with severe pneumonia in the intensive care
unit (ICU) represent a major concern for physicians because of
the high mortality and morbidity rate attributable to these epi-
sodes [1–3]. Severe community acquired pneumonia (SCAP)
occurs in approximately 18–36% of all CAP [3]. The mortality
rate for community acquired pneumonia (CAP) is <5% for
outpatient cases, it rises to 10% in admitted ward patients
and can exceed 30% in patients admitted to intensive care unit
(ICU) [4]. Tan et al. and Hirani et al. reported a mortality rate
of 67% and 58% in patients with SCAP, respectively [1,5]. A
lot of effort was focused upon the need for a best deﬁnition
that could predict illness severity [6]. In 1993, the American
Thoracic Society (ATS) proposed a deﬁnition of severe CAP
requiring ICU admission [7]. Since that time, these criteria
have been updated twice [8,9]. Liapikou et al. describes a nicely
performed study that validates the IDSA/ATS prediction rule
when it comes to major criteria but fails to conﬁrm the validity
of the minor criteria [10]. These ﬁndings are acceptable but are
not very surprising, and it is incumbent upon investigators to
continue to explore the usefulness of the minor criteria [11].
On the other hand Angus et al. concluded that none of the
available prediction rules for severe CAP were adequately
robust to guide clinical care at the current time [6]. During past
decades many strategies have been implemented with the aim
to optimize the outcome of patients with severe lung infections,
and it is widely believed that in critically ill patients, when oxy-
gen delivery fails to meet oxygen demand, an oxygen debt with
global tissue hypoxia ensues [11,12]. As the condition became
more complicated such as in severe sepsis and septic shock the
lactate concentration increased. This increase in lactate is the
result of an anaerobic production (via the Na–K ATPase chan-
nel) and a decrease in lactate utilization [13–15]. Lactate clear-
ance, measurement of the lactate level at two consecutive
times, is an inexpensive and simple clinical parameter that
can be obtained by a minimally invasive means [16–18]. This
parameter represents kinetic alteration of the anaerobic metab-
olism that makes it a potential parameter to evaluate disease
severity and intervention adequacy. Lactate clearance early
in the hospital course may indicate a resolution of global tissue
hypoxia and is associated with improved outcome [19].
In addition, several studies have described a correlation
between baseline lactate concentration and mortality of ICU
patients [20–23]. In this study we follow lactate clearance after
admission for 24 h which could be an indicator of outcome in
severe community acquired pneumonia. So, we investigated
the prognostic value and the clinical utility of lactate clearance
in the intensive care unit during the period of disease
presentation.Aim of the work
To study the prognostic value and the clinical utility of the lac-
tate clearance in intensive care unit as a marker for predicting
poor outcomes in patients with severe pneumonia.
Patients and methods
This study was conducted prospectively between October 2012
and January 2014 at the Critical Care department of the Cairo
University. This study was approved by the local ethics com-
mittee of the department and a written consent from the
patient or next of kin was required. Forty-six consecutively
admitted adult patients diagnosed as severe community
acquired pneumonia depending on the Infectious Disease Soci-
ety of America–American Thoracic Society guidelines with the
revised American Thoracic Society criteria. This guideline
comprises two major criteria (the requirement for mechanical
ventilation and vasopressor support) or three minor criteria
(comprising respiratory rate, PaO2/FiO2 ratio, multilobar inﬁl-
trates, confusion, uraemia, leucopenia, thrombocytopenia,
hypothermia and hypotension requiring aggressive ﬂuid resus-
citation) [9].
For all patients included in the study, full history and clin-
ical examination were performed regularly. Laboratory work
up including blood picture, sputum and blood culture was
requested. Other investigations including arterial blood gases
and chest X-rays were done for all patients in the study. All
patients were invasively monitored with a central venous cath-
eter capable of taking blood samples (superior vena cava) for
measuring mixed venous blood which was measured when
patients arrived in ICU and after 8 and 24 h. Appropriate
specimens were taken for culture, and antibiotics were admin-
istered as soon as possible. Blood pressure was monitored by
either a non invasive automated cuff sphygmomanometer or
an arterial catheter according to the clinical team’s judgement.
The inclusion of the patient in this study was initiated at the
time of ICU admission (H0), with lactate measurement. Reas-
sessment of lactate level was done after 8 h and also another
lactate measurement after 24 h. In a trial to follow the guide-
line for management and to optimize oxygen delivery (DO2)
and reach a ScvO2P 70%, ScvO2 was measured through a
central venous blood sample done at the same time with lac-
tate. Lactate clearance was deﬁned by the equation [(lactate
initial  lactate delayed)/lactate initial] · 100%. Survival was
followed-up during 28 days. During the study resuscitation
by inotropic medications, the patient’s physiological parame-
ters were measured routinely. All data needed to calculate
the Acute Physiology and Chronic Health Evaluation
(APACHE II) score were recorded.
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with
- Diabetic ketoacidosis
- Patients on metformin
- Renal failure on dialysis
- Terminal Liver cell failure
- Terminal cancer
- Severe heart failure
Patients needed for mechanical ventilation or vasopressor
support were assessed by the following variables: confusion,
oxygen saturation <90% on room air, respiratory rate
>30 breaths/min, mean arterial blood pressure <65 mmHg
or systolic blood pressure <90 mmHg.
The two groups, high lactate clearance group (group 1) and
low lactate clearance group (group II), were compared for
association of various parameters.
Data were analyzed, mean ± SD is given for normally dis-
tributed metric variables, frequencies and percentages are
given for non-metric variables. Shapiro–Wilk test was used
to test normality. Independent sample t test was applied to
observe mean differences among the two groups. Fisher’s exact
test was applied to observe associations for qualitative vari-
ables. A logistic regression was performed to discriminate if
different variables such as lactate clearance H0–H24,
APACHE II score and inotopic drugs were independently cor-
related to the survival status. Goodness of ﬁt of the model was
assessed using the Hosmer–Lemeshow test. Statistical analysis
was realized by SAS 9.1.3 software. P-value of <0.05 was con-
sidered as statistically signiﬁcant.
Results
Demographic data and patient characteristics
We studied 46 critically ill patients admitted to ICU as severe
community acquired pneumonia. The demographic data and
character of those patients with severe pneumonia are pro-
vided in Table 1. Most of patients in the current study were
above the age of 60 years. 25 patients had high lactate clear-
ance [more than 40%] those patients were included in group
1, whereas 21 had low lactate clearance [40% or lower] and
they were included in group II.
Comparison between group 1 & group II
The patients were divided into two groups according to the
results of lactate clearance in 24 h.Table 1 Demographic data, baseline characteristics outcome betwe
Group 1 (n= 25)
Age 63.4 ± 11.4
Sex, male, % n= 16 (64%)
APACHE II score 18.1 ± 4.6
LOS in ICU 6.3 ± 4.6
Use of inotropic drugs, % n= 1 (4%)
Rate of intubation, % n= 2 (8%)
Mortality in 28 days, % n= 4 (16%)Group 1: Patients included in this group had lactate clear-
ance more than 40%
Group II: Patients included in this group had lactate clear-
ance of 40% or less.
There was no signiﬁcant difference in the age and sex distri-
bution between both groups. All the patients received antibiot-
ics and were mechanically ventilated when their clinical
condition necessitated it. Out of 21 patients included in group
II, inotropic drugs were used in 8 patients (38%) whereas one
patient only in group 1 needed norepinephrine infusion to
maintain blood pressure. The rate of intubation was signiﬁ-
cantly high in group II as 13 patients (61%) were intubated
which was signiﬁcantly higher than group 1. The mean
APACHE II score was 21.4 ± 6.8 in group II versus
18.1 ± 4.6 in group 1 which was signiﬁcantly higher in group
II (p= 0.043). Also there was statistical difference in the ICU
length of stay (LOS), being longer in group II (Table 1). The
heart rate and CVP were recorded and no statistical difference
was observed between both groups, whereas MAP was signif-
icantly lower in group II (Table 2). The results of different lab-
oratory studies including complete blood picture and renal
function showed no signiﬁcant difference between both
groups. However the PH was signiﬁcantly lower in group II
(Table 3). Over the ﬁrst 24 h three readings for mixed venous
oxygen were recorded and included in the analysis. Only the
one recorded after 24 h of ICU admission was signiﬁcantly
high in group 1 (Table 4). All indices of blood lactate clearance
over the ﬁrst 24 h were higher in group 1 compared to group
II, however it was only signiﬁcantly high after 24 h, p-value
0.01 (Table 5).
Logistic regression found that only the lactate clearance
H0–H24, APACHE II score and inotopic drugs were indepen-
dently correlated to a survival status with a p= 0.039 [odds
ratio = 0.33 (95% CI 0.02–0.67)], p= 0.01 [odds ratio = 3.1
(95% CI 1.04–6.3)] and 0.023 [odds ratio = 1.7 (0.9–4.7)],
respectively (Table 6).
Main pathogens isolated in all patients
Streptococcus pneumoniae, Staphylococcus aureus and Pseudo-
manas aeruginosa were the main pathogens isolated in patients
admitted to ICU for severe pneumonia (Table 7).
Intensive care mortality
The total number of non survival cases in our study was 14
patients, 4 patients in group 1 and 10 in group II. As 46.7%
of patients died in the ﬁrst 28 days in group II, this was signif-
icantly higher than group I. It is necessary to stress that allen high and low lactate clearance groups.
Group II (n= 21) P value
65.3 ± 13.2 0.36
n= 12 (57%) 0.2
21.4 ± 6.8 0.043
14.7 ± 8.3 0.001
n= 8 (38%) 0.002
n= 13 (61%) 0.001
n= 10 (47.6%) 0.026
Table 2 Hemodynamic data in high and low lactate clearance
groups.
Group 1 Group II P value
Temperature, C 38.4 ± 1.2 38.2 ± 1.7 0.7
Heart rate, beats/min 111.2 ± 14.2 108 ± 19.7 0.42
MAP, mm Hg 82.5 ± 18.9 69.9 ± 21.4 0.04
CVP, mm Hg 5.7 ± 4.7 6.3 ± 5.3 0.8
Table 7 Types of organisms isolated from different cultures.
Organism Number (%) Culture
Streptococcus pneumoniae 16 (34.7%) Sputum & ETA
Staphylococcus aureus 8 (17.3%) Sputum & ETA
Pseudomanas aeruginosa 7 (15.2%) Sputum & ETA
Klebsiella pneumoniae 4 (8.6%) ETA & Blood
MRSA 3 (6.5%) ETA & Blood
Others or unidentiﬁed 8 (17.3%) Sputum & ETA &Blood
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had lactate clearance below 5% and they belonged to group II.
Discussion
Severe community-acquired pneumonia (CAP) is an increas-
ingly common reason for admission to the intensive care unit
(ICU) [11].
There is much interest in ﬁnding biomarkers that can assist
in the early identiﬁcation of patients who are, or continue to
be, at high risk of death [24]. Lactate is mainly cleared by
the liver, but the kidneys and skeletal muscles are also involved
[24]. It may be cleared by oxidation via the Krebs cycle, or by
gluconeogenesis via the Cori cycle [25]. Blood pH is also anTable 3 Laboratory results in both groups.
Group 1
Hematocrit, % 35.4 ± 5.7
WBC, per mm3 14.2 ± 7.8
Platelet, per mm3 192,000 ± 69,000
Creatinine, mg/dL 1.9 ± 0.7
Albumin, g/dL 3.5 ± 0.8
pH 7.32 ± 0.03
Table 4 ScvO2 monitoring in both groups.
Mixed venous oxygen ScvO2 H0 (%)
Group 1 69.8 ± 8.3
Group II 68.2 ± 10.9
P value 0.58
Table 5 Lactate clearance in both groups.
Lactate clearance Lactate in mmol/L H0
Group 1 3.3 ± 5.4
Group II 4.5 ± 9.6
P value 0.31
Table 6 Multivariate study to correlate Lactate clearance, APACH
Lactate Cl H0–H24
Odd ratio 95% CI 0.33 (0.02–0.67)
P value 0.039important determinant of the lactate metabolism, as alkalosis
enhances lactate production [24] and alters lactate elimination
[26]. So lactate clearance may be the preferred goal to target as
we supposed that a fall in lactate concentration following the
initiation of treatment for acute ill patients may be due to cor-
rection of an oxygen debt [15]. Lactate clearance may be spe-
ciﬁc either to the severity of the acute illness, or to the stage
of illness [25]. The etiology of persistent hyperlactatemia may
be multifactorial, accompanying a hypovolemic stage, a com-
pensatory or vasodilatory stage, myocardial suppression, or
impaired tissue oxygen utilization after hemodynamic optimi-
zation [14]. In this latter stage, lactate clearance may be partic-
ularly helpful in identifying those patients at continuedGroup II P value
36.8 ± 6.9 0.39
15.7 ± 6.9 0.34
206,000 ± 98,000 0.07
2.6 ± 0.9 0.06
3.3 ± 0.78 0.6
7.25 ± 0.04 0.036
ScvO2 H8 (%) ScvO2 H24 (%)
72.9 ± 6.5 74.9 ± 5.5
69.1 ± 7.2 69.8 ± 6.6
0.32 0.04
Lactate clearance H0–H8 Lactate clearance H0–H24
21.6 ± 22.3% 41.6 ± 39.4%
14.1 ± 12.5% 19.2 ± 10.3%
0.06 0.01
E II score and inotopic drugs to survival status.
APACHE II score Inotopic drugs
3.1 (1.04–6.3) 1.7 (0.9–4.7)
0.01 0.023
Prognostic value of lactate clearance in SCAP 1057increased risk of mortality. As few as 20% of patients in the
highest Pneumonia Severity Index class (class V) require
ICU admission, illustrating the system’s limited value for the
critical care community [10]. It is reasonable to hypothesize
that the degree of low clearance of lactate correlates with the
patient outcome and could be of prognostic value. This may
be more easier and if so it will be of value as the known scores
have important limitations arising from the use of 28-day mor-
tality as an outcome [17]. The scores may underestimate sever-
ity in the young population and may perform less well when
considering outcomes such as intensive care unit (ICU) admis-
sion or requirement for mechanical ventilation or vasopressor
support [9,11]. In the current study there was no signiﬁcant dif-
ference in the age between both groups, however the mean
arterial blood pressure was signiﬁcantly lower in group II. It
is important to stress that initial lactate measurement in both
studied groups was not statistically signiﬁcant. However, the
dynamic indices of lactate homeostasis, which studied not only
the magnitude but also duration and trend over time, may be
even more useful in predicting outcome. In support of this
hypothesis, a number of small single center observational stud-
ies, principally in patients with severe sepsis and septic shock
suggested that early changes in blood lactate concentration
may be useful in identifying those at high risk of death
[16,27–29].
The corner stone of our study was lactate clearance where it
was a signiﬁcant predictor of death as the p= 0.039 [odds
ratio = 0.33 (95% CI 0.02–0.67)]. On the other hand it was
shown that achievement of good values of ScvO2 was corre-
lated to group 1 which was associated with high lactate clear-
ance, less use of inotropics, shorter LOS, lower rate of
intubation and mortality. However measurement of lactate
clearance is potentially more easy and non invasive, also did
not require resources or trained staff [11]. Our data showing
that lactate clearance in sever Pneumonia is non-inferior to
ScvO2 monitoring. Our results were supported by Jones
et al. who studied lactate clearance versus central venous oxy-
gen saturation as goals of early sepsis therapy [18].
In the current study there was a signiﬁcant difference in
the length of ICU stay as it was shorter in group 1. Our
study highlights the role of using lactate clearance as a mar-
ker of hypo perfusion, this was reﬂected on signiﬁcant usage
of inotopic medication in group II with low lactate clearance.
The primary aim was to assess the prognosis of those patients
with high lactate clearance. Our results showed decreased
mortality rate in patients with high lactate clearance (group
1). However, it is still unclear if these could be explained or
related to high lactate clearance or other factors like
APACHE II score or both. Multivariate study to correlated
different factors that could affect outcome revealed the
importance of lactate clearance by ﬁnding that only the lac-
tate clearance H0–H24, APACHE II score and inotopic
drugs were independently correlated to a survival status. Per-
sistent hyperlactatemia may be independent of other hemody-
namic factors and portends a worse prognosis [13]. In spite of
that, it could be a unique simple value and marker of good
resuscitation [18]. In the current study, lactate clearance after
24 h was independently correlated to a survival status. Our
study highlights the role of using lactate clearance at the
same time to try to illustrate other factors that could be cor-
related to outcome. Our ﬁndings were supported by Nguyen
et al. who reported in a prospective observational study an11% decrease in mortality for each 10% decrease in lactate
clearance [16]. This was also conﬁrmed by Nichol et al.
2010 in a retrospective multi-center study who studied the
effect of relative hyperlactatemia on hospital mortality in crit-
ically ill patients [30]. Mixed central venous oxygen satura-
tion is correlated to the central venous saturation and our
data were found to be signiﬁcantly different between both
groups after 24 h. On the other hand Varpula et al. supported
those published in guidelines [31] as a SvcO2 < 70% is inde-
pendently associated with mortality. Moreover, even if it
remains controversial, early goal-directed therapy (H0–H6)
adapted to a target of ScvO2 has decreased the mortality rate
in septic shock patients [32].
In the current study a microbiological agent was identiﬁed
for more than 90% of the cases. The most frequently detected
pathogens were S. pneumoniae in sixteen patients (34.7%).
This was comparable to that reported by Johansson et al.
2010 who mentioned that the most frequently detected patho-
gens in CAP were S. pneumoniae (70 patients [38%]) [33].
As previously mentioned that lactate clearance was a
signiﬁcant predictor of death in this study, patients whose
lactate clearance was less than 5% died in the ﬁrst 5 days.
Whereas John et al. found in a critically ill surgical patient
population that no patient whose lactate level was still
greater than 2.0 mmol/dL at 96 h reached normal values.
Of note, 33% (4 of 12) of these patients expired late in their
postoperative course [34]. However, an elevated serum lactate
level is not uniformly accepted, as a marker of cellular
hypoxia. Gore et al. states that the increase in serum lactate
seen during stressed states is the result of accelerated pyru-
vate oxidation, accelerated glycolysis, and decreased hepatic
clearance [35]. We should stress that we excluded patients
that had diabetic ketoacidosis or those on metformin and
also patients with terminal Liver cell failure. Finally, we
reported a correlation between lactate clearance and survival
in patients with severe community acquired pneumonia
admitted to ICU.
Limitations
We acknowledge that the study has some limitations including
the inability to determine whether some clinical conditions
have been associated with impaired clearance of lactate such
as liver cell failure and in patients that received certain drugs,
in addition to increased glucose metabolism and thus lactate
production. We excluded those types of patients to overcome
this issue. Another factor that may affect the results was the
therapeutic action that was performed. We controlled such fac-
tors by strictly following the policy of ICU according to the
intended goals of resuscitation.Conclusion
Our study suggests that lactate clearance could be used as a
useful biomarker which is inexpensive and a reliable predictor
of patient outcome in critically ill patients admitted to ICU by
severe community-acquired pneumonia. Further clinical trials
are needed to conclusively establish lactate clearance as a man-
agement goal and an outcome measure to be targeted during
the most critical phases of severe community-acquired pneu-
monia patients.
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